Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Buzzy® and HSTT take the sting out of kids' injections

NCT ID NCT07509164

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether two simple, low-cost tools—Buzzy® (a vibrating device) and HSTT (a quick injection technique)—can reduce pain and fear in children aged 4 to 6 during intramuscular shots in the emergency department. 120 children participated, and researchers measured their pain and fear levels using special picture scales. The goal is to find easy ways to make injections less scary and painful for young kids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jul 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 6 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The child must be in the 4-6 age group, * The IM medication must be ordered by a doctor, * The IM administration must be performed in the pediatric emergency department, * The child must not have a disease causing chronic pain, * The child must not have a neurodevelopmental disorder, * The child must not have received analgesics in the last 6 hours, * The child must not have a history of fainting during injection, * The child must not have mental retardation, * The child must not have scar tissue or muscle atrophy at the injection site, * The child's percentile must be between 10th and 90th, * The families and children must agree to participate in the study. Exclusion Criteria: * -Being younger than 4 years old, * Being older than 6 years old, * Having scarring or muscle atrophy at the injection site, * Having communication problems in the child or parent, * Having a percentile below 10 (cachectic) or above 90 (obese), * Families and children not agreeing to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain Respiration Disorders respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sakarya University

    Sakarya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.